Bibliographic Citation
| - Kandel M., Allayous C., Dalle S., Mortier L., Dalac S., Dutriaux C., Leccia M.T., Guillot B., Saiag P., Lacour J.P., Legoupil D., Lesimple T., Aubin F., Beylot-Barry M., Brunet-Possenti F., Arnault J.P., Granel-Brocard F., Stoebner P.E., Dupuy A., Maubec E., Grob J.J., Dréno B., Rotolo F., Ballon A., Michiels S., Lebbe C., Borget I.. Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort. European Journal of Cancer, Elsevier, 2018, 105, pp.33--40. ⟨10.1016/j.ejca.2018.09.026⟩
- Kandel M., Dalle S., Mortier L., Dalac S., Dutriaux C., Leccia M.T., Guillot B., Lacour J.P., Beylot-Barry M., Granel-Brocard F., Stoebner P.E., Dupuy A., Michiels S., Lebbe C., Borget I. . Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort . European Journal of Cancer, 2018, 105, pp.33--40 . ⟨10.1016/j.ejca.2018.09.026⟩
|